Kalvista Pharmaceuticals Inc (KALV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 01-2020 | 10-2019 | 07-2019 | 04-2019 | 01-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,532 | -13,241 | -7,338 | N/A | -12,290 |
| Depreciation Amortization | 518 | 327 | 156 | N/A | 256 |
| Accounts payable and accrued liabilities | 133 | -558 | 392 | N/A | 1,748 |
| Other Working Capital | -13,091 | -8,203 | -5,593 | N/A | -15,920 |
| Other Operating Activity | 2,774 | 2,586 | 1,108 | 0 | 352 |
| Operating Cash Flow | $-32,198 | $-19,089 | $-11,275 | $N/A | $-25,854 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -212 | -212 | -98 | N/A | -806 |
| Purchase Of Investment | -45,114 | -42,561 | -19,646 | N/A | -55,419 |
| Sale Of Investment | 52,052 | 39,729 | 18,214 | N/A | 850 |
| Investing Cash Flow | $6,726 | $-3,044 | $-1,530 | $N/A | $-55,375 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -53 | -54 | -54 | N/A | -155 |
| Common Stock Issued | 11,636 | 11,592 | 11,454 | N/A | 87,943 |
| Financing Cash Flow | $11,583 | $11,538 | $11,400 | $N/A | $87,788 |
| Exchange Rate Effect | 498 | 308 | -494 | N/A | -1,269 |
| Beginning Cash Position | 32,006 | 32,006 | 32,006 | N/A | 51,055 |
| End Cash Position | 18,615 | 21,719 | 30,107 | N/A | 56,345 |
| Net Cash Flow | $-13,391 | $-10,287 | $-1,899 | $N/A | $5,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,198 | -19,089 | -11,275 | N/A | -25,854 |
| Capital Expenditure | -212 | -212 | -98 | N/A | -806 |
| Free Cash Flow | -32,410 | -19,301 | -11,373 | 0 | -26,660 |